Develops treatments for rare diseases.
Jun 2026Revenue $106M/yrExpenses $89.3M/yr
Reached break-even Jan 2026
Figures by year
When did Eton Pharmaceuticals become profitable?
Its revenue passed its expenses in Jan 2026. In the 12 months to Jun 2026, revenue was $106M and expenses $89.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $80.0M | $80.8M | −$844K |
| Dec 2024 | $39.0M | $41.6M | −$2.60M |
| Dec 2023 | $31.6M | $32.8M | −$1.19M |
| Dec 2022 | $21.3M | $29.5M | −$8.26M |
| Dec 2021 | $21.8M | $23.3M | −$1.50M |
| Dec 2020 | $39.0K | $27.1M | −$27.1M |
| Dec 2019 | $959K | $19.6M | −$18.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.